Nexocura: Accelerating Bone Healing Through Targeted Nanotherapy
Nexocura is developing a novel, non-surgical treatment to help bone fractures heal faster and more effectively, potentially impacting recovery for millions of fracture patients.
News Feed
IVVA: Expanding the Capabilities of Telemedicine Through Video-Based Vital Sign Monitoring
The IVVA capstone team is advancing telemedicine by developing software to measure vital signs from standard video, enhancing remote clinical assessment without extra hardware.
A Novel Therapeutic Strategy for Nephropathic Cystinosis
MTM students colaborate with the UCSF Sarwal Lab to develop a novel nanoparticle-delivered therapy for Nephropathic Cystinosis to prevent end-stage renal disease in children.
FaceShift: Innovating Craniofacial Care Through 3D Printing Technology
The FaceShift capstone team is revolutionizing surgical planning for craniofacial deformities, leveraging 3D printing and advanced imaging to create patient-specific models.
Dr. Shuvo Roy at the University of California, San Francisco
Meet Dr. Shuvo Roy, a pioneer in the field of bioengineering and the lead behind The Kidney Project, inspiring the next generation of MTM innovators.
IntelliStent®: A Non Surgical Endovascular Treatment for Congenital Heart Disease and Cardiomyopathy
Congenital heart disease treatment is going non-surgical. The IntelliStent team is developing a smart endovascular stent, a treatment that avoids invasive open-heart surgery.
NextSense: Digital Interventions for ADHD
NextSense is exploring digital, wearable interventions to manage ADHD, using data-driven insights to deliver personalized, non-drug support for neurodivergent individuals.
Director Highlight: Verna Rodriguez
Meet Verna Rodriguez, MTM Program Director, and discover her vision for growth and commitment to uniting engineers and clinicians to solve major medical challenges.
Program Highlight — “Lean Transfer”
See how our “Lean Transfer” curriculum teaches rapid prototyping, regulatory navigation, and market validation to move medical devices from lab to clinic—and to patients.
UCB/UCSF’s Master of Translational Medicine Unveils New Therapeutics Track in 2024
Launching a new Therapeutics Track in 2024: deep training in drug discovery, clinical trials, and pharmaceutical regulatory strategy.